Bioprocess Technology Market
Bioprocess Technology Market by Type (Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Infiltration), by Application (Biopharmaceuticals, Specialty Products, Industry Chemicals), by End-User- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021-2031
Bioprocess technology market valuation is anticipated to expand at a CAGR 14.8% over the forecast period of 2021 to 2031, as per the latest study by Fact.MR, a market research and competitive intelligence provider. Demand for bioprocess engineering in biotechnology is set to be valued at around US$ 78.8 Bn by 2031-end, which amounts to around 4% share of the overall biotechnology market.
Globally, the bioprocess technology market experienced a downfall in its demand curve in 2020 due to the COVID-19 pandemic. However, owing to rising demand for next-generation bio-based products, followed by increasing production of bio-based products of late, the market has bounced back since the beginning of 2021. Fact.MR. has analysed that bioprocess technology in biopharmaceutical applications holds a significant market share, a trend that is likely to continue in the near future as well.
|Bioprocess Technology Market Size 2020||US$ 16.5 Bn|
|Market Forecast Value for 2031||US$ 78.8 Bn|
|Global Growth Rate (2021 to 2031)||14.8% CAGR|
|North America Market Size in 2020||US$ 5.4 Bn|
Demand Analysis of Bioprocess Technology from 2016 to 2020 Vs Market Outlook for 2021 to 2031
The global bioprocess technology market has witnessed a strong growth rate of 11.6% over the historical period with sales pegged at US$ 16.5 Bn in 2020. Growing focus on preventing measures along with alternative medicines for specific uses are driving the sales figures of bioprocess technology. New production sites and expansion of existing sites in emerging markets are key factors influencing overall market growth.
The global bioprocess technology space has evolved remarkably in the past half-decade on the back of increasing investments in new technologies to overcome performance and quality issues associated with the manufacturing of bioprocess products.
Shifting preference towards bio-based products derived from biodegradable and fossil fuels is creating growth avenues in potential markets. Based on the aforementioned trends, global bioprocess technology demand is expected to surge at a CAGR of 14.8% over the period (2021-2031).
- Application of bioprocess technology in biopharmaceuticals holds the highest market share and is anticipated to rise at a CAGR 13.4% over the forecast period.
- North America accounted for a major share of the market. The regional market expanded at a CAGR 11.7% during 2016-2020 and held approx. 33% global market share in 2020.
- Demand for bioprocess technology in hospitals and research labs is anticipated to increase at a significant pace over the forecast period.
- Cell culture bioprocess technology is the most significant type adopted by consumers across the globe.
Avail customized purchase options for your needs
What are the Prominent Driving Factors for the Bioprocess Technology Business?
Primary reason behind the swift progress of bioprocess technology can be accounted to the evolution of biopharmaceutical and biotechnology industries.
Increasing prevalence of chronic diseases is also one of the main factors driving demand for bioprocess technology. Upsurge in demand for new drugs initiates the need for bioprocess technology. Additionally, personalized treatment for diseases such as cancer is intensifying demand for various bioprocess therapies, including cell therapy.
In recent years, the importance of research & development in the life sciences industry has been strongly promoted. Due to this trend, government support for pharmaceutical and biotech industries is also increasing.
Another rapidly growing bioprocess technology field is oligosaccharide manufacturing. Due to the uncountable health benefits in treating chronic diseases, they have numerous promising applications in the F&B industry. These effects have led to a surge in market demand for bioprocess technology.
Why is the U.S. a Prominent Market for Bioprocess Technology?
Over the period of 2016-2020, bioprocess technology demand in the United States surged at a CAGR 12.1% and reached over US$ 5.4 Bn in 2020, which is anticipated to top US$ 26 Bn by 2031-end.
The U.S. is estimated to account for around 88.7% value share in North America. Increasing requirements for upstream bioprocess technology equipment in the country is the primary reason for its dominance. Escalating living standards, increasing disposable income, along with growing health consciousness are also the reasons behind rapid growth of the bioprocess technology market in the U.S.
Will Bioprocess Technology in Germany Evolve at a Rapid Pace?
The market for bioprocess technology in Germany is anticipated to rise at a CAGR 11.2% over the forecast period.
The country held over 27% of overall European demand in 2020. Rising inclination towards bio-based medicines is the prime factor behind high demand for bioprocess technology in Germany. Other factors such as reduced and reuse of wastage also fuelling the requirement for bioprocess technology in the country.
Why India is the Highest Contributor to Bioprocess Technology in South Asia & Oceania?
The bioprocess technology market in India is anticipated to rise rapidly at a CAGR 19% through 2031. The country held over 52% of the South Asia & Oceania market share in 2020.
Growing production of biopharmaceuticals such as vaccines and recombinant proteins are the primary reasons behind rapid market growth. The country is also one of the leading manufacturers of vaccines, which inevitably makes it a key market for bioprocess technology.
An Adaptive Approach to Modern-day Research Needs
Which is the Most Preferred Bioprocess Technology Type?
Bioprocess technology has become one of the most significant sectors in the healthcare industry with the advent of new technologies in recent years. Cell culture bioprocessing is the most prominent bioprocessing technology type, and the segment is anticipated to surge at a CAGR 18.7% over the decade.
Rising investments in research and technology are also proliferating demand for cell culture bioprocess technology. Cell culture is used as a model system to studying basic cell biology and biochemistry. Biological studies on the effect of drugs, process of aging, and interaction between cells and disease-causing agent like bacteria and virus are significantly fuelling bioprocess technology demand.
Why is the Biopharmaceutical Sector the Most Prominent Revenue Generator for Bioprocess Technology?
The biopharmaceuticals sector across the globe has continued its positive momentum over the past half-decade. The global biopharmaceutical industry was valued at around US$ 320 Bn in 2020, and is anticipated to top US$ 490 Bn by 2031. Innovative drugs for sustained patient outcomes will continue to play a key role in the growth of the bio-pharmaceuticals sector. Looking into the demand trend, manufacturers of biopharmaceuticals are focusing on increasing their production to cater high market requirements.
Key players are focusing on market expansion by following both, inorganic and organic approaches.
- In 2017, GE Healthcare acquired Puridify, a bioprocessing start-up that develops nanofiber-based platform purification technology for the production of biopharmaceutical. Puridify's FibroSelect technology complements the bead resins and chromatography membranes that are utilized in downstream bioprocessing processes today, achieving faster mass transfer & scalability, and ease of use.
|Historical Data Available for||2016-2020|
|Market Analysis||Value in US$ Mn|
|Key Regions Covered||
|Key Countries Covered||
|Key Market Segments Covered||
|Key Companies Covered||
|Pricing||Available upon Request|
Bioprocess Technology Industry Research Key Segments
- Cell Culture
- Cell Expansion
- Flow Cytometry
- Cell Line Development
- Virus Infiltration
- Specialty Products
- Industry Chemicals
- Environment Management Aid
By End User
- Research labs
- Medical Institutions
- FAQs -
In 2020, the bioprocess technology market surpassed a valuation of US$ 16.5 Bn.
Demand for bioprocess technology is projected to rise at a CAGR of 14.8% during 2021 – 2031.
Bioprocess technology increased at a CAGR of 11.6% during 2016 – 2020.
Flow cytometry technology is the talk of the town in this market landscape.
Increasing spending on life science research and strong biologics pipeline are prime reasons driving demand for bioprocess technology.
Tier-1 providers of bioprocess technology account for over 58% share in the market.
Top 5 countries driving demand for bioprocess technology are the U.S., Germany, China, Japan, and India.
North America accounted for nearly 33% of global bioprocess technology value share in 2020.
The European market for bioprocess technology is projected to expand at a CAGR of 14.6% during 2021 – 2031.
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.